Cardinal Health Stock News

Cardinal Health stock rose deeper into a buy zone Thursday on a solid third-quarter report and guidance hike.

First quarter revenue increased 5% to $67.5 billion GAAP 1 operating earnings increased 13% to $753 million; GAAP diluted EPS increased 27% to $2.38 Non-GAAP operating earnings increased 17% to $1.0 billion; non-GAAP diluted EPS increased 28% to $3.26 Cardinal Health raises fiscal year 2027 non-GAAP EPS guidance2 to $12.80 to $13.00, 17% to 19% growth3 from its FY26 ex-tariff refund baseline an...

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continui...

Cardinal Health stock rose slightly early Tuesday on better-than-expected fiscal fourth-quarter earnings, but sales missed.

U.S. drug distributor Cardinal Health on Tuesday forecast fiscal 2027 profit well above Wall Street expectations after ​topping fourth-quarter profit estimates, driven by sustained demand ‌for specialty drugs.

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.